This inventor holds 1 USPTO granted patent. Top assignee: Atlantic Pharmaceuticals (Holdings) Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Michael Webb - Innovator in Oligonucleotide Formulation
Introduction
Michael Webb is a notable inventor based in Bishops Stortford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of oligonucleotides. His innovative work has led to the development of a new formulation that holds promise for various applications.
Latest Patents
Michael Webb holds a patent for a formulation related to the oligonucleotide of SEQ ID NO:1. This patent represents his commitment to advancing pharmaceutical science and improving therapeutic options.
Career Highlights
Michael is currently employed at Atlantic Pharmaceuticals (Holdings) Limited, where he continues to work on groundbreaking projects. His role at the company allows him to apply his expertise in the development of new pharmaceutical formulations.
Collaborations
Michael has collaborated with talented individuals such as Toby Wilson Waterworth and Lorin Johnson. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Michael Webb is a dedicated inventor whose work in oligonucleotide formulation exemplifies the spirit of innovation in the pharmaceutical industry. His contributions are paving the way for future advancements in this critical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile